Photocurable composition, three-dimensional molded article, dental product, and splint
Patent Information
- Application Number
- JP2024511802
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Filing Date
- 2024-09-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Dental products, such as splints, require both high mechanical strength and transparency, but existing photocurable resins often compromise on one attribute to achieve the other, leading to insufficient performance in applications like temporomandibular joint disorder treatments.
A photocurable composition containing specific photopolymerizable components like mono(meth)acrylic monomers, di(meth)acrylic monomers, and tri(meth)acrylic monomers, along with a photopolymerization initiator, is irradiated with specific wavelengths of light to achieve a cured product with both high mechanical strength and transparency.
The composition produces a cured product with bending strength of 50 MPa or more and bending elastic modulus of 1500 MPa or more, while maintaining transparency, suitable for dental products like splints.
Abstract
Description
Photocurable composition, three-dimensional object, dental product and splint
[0001] The present disclosure relates to a photocurable composition, a three-dimensional object, a dental product, and a splint.
[0002] In recent years, dental products such as dental prostheses and instruments used in the oral cavity have been studied. For example, from the viewpoint of the efficiency of forming these dental products, a method for producing three-dimensional objects such as dental products by stereolithography using a 3D printer is known (see, for example, Patent Document 1).
[0003] Patent No. 4160311
[0004] Incidentally, dental products (e.g., splints) worn in the oral cavity may be worn constantly, such as during the day, and therefore aesthetics may be required. For example, to enhance aesthetics, the transparency of the dental product may be increased. One method for increasing transparency is to use a method that does not use a coloring component such as a coloring material, but the transparency may be insufficient due to the coloring of the photocurable resin itself. In such cases, it is possible to increase transparency by reducing the thickness of the product itself. However, reducing the thickness tends to reduce mechanical strength, and the mechanical strength may be insufficient in applications that require a certain level of mechanical strength for use in the oral cavity, such as splints for treating temporomandibular joint disorders.
[0005] An object of one aspect of the present disclosure is to provide a photocurable composition capable of producing a cured product that combines high mechanical strength and high transparency, as well as a three-dimensionally shaped object, a dental product, and a splint that include a cured product of the photocurable composition.
[0006] The means for solving the above problems include the following aspects: <1> A photocurable composition containing a photopolymerizable component and a photopolymerization initiator, wherein the photocurable composition is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm. 2 The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm. The object A1 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2After irradiation, both sides of the 50 mm × 40 mm surface were polished to prepare a rectangular plate-shaped test piece A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm. * ab is 6.0 or less, and the photocurable composition is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm 2 The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm. The object A2 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2<2> The photopolymerizable component comprises one or more (meth)acrylic monomers (A) selected from the group consisting of a mono(meth)acrylic monomer (A-1) having one (meth)acryloyloxy group and not having a cyclic structure, and a di(meth)acrylic monomer (A-2) having two (meth)acryloyloxy groups, not having a cyclic structure, and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is 25 Å or more; The photocurable composition according to <1>, comprising one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups; and a (meth)acrylic monomer (C) having one (meth)acryloyloxy group and having an aromatic structure.<3> A photocurable composition containing a photopolymerizable component and a photopolymerization initiator, wherein the photopolymerizable component comprises one or more (meth)acrylic monomers (A) selected from the group consisting of a mono(meth)acrylic monomer (A-1) having one (meth)acryloyloxy group and not having a cyclic structure, and a di(meth)acrylic monomer (A-2) having two (meth)acryloyloxy groups, not having a cyclic structure, and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is 25 Å or more; A photocurable composition comprising one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups, and a (meth)acrylic monomer (C) having one (meth)acryloyloxy group and having an aromatic structure. <4> The photocurable composition according to <2> or <3>, which satisfies at least one of the following (1) or (2): (1) The (meth)acrylic monomer (A) contains the mono(meth)acrylic monomer (A-1), and the molecular weight of the mono(meth)acrylic monomer (A-1) is 100 to 500. (2) The photocurable composition according to <2>, in which, when the (meth)acrylic monomer (A) contains the di(meth)acrylic monomer (A-2), the molecular weight of the di(meth)acrylic monomer (A-2) is 400 to 1,000. <5> The photocurable composition according to any one of <2> to <4>, which satisfies at least one of the following (3) to (5): (3) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-1), and the molecular weight of the di(meth)acrylic monomer (B-1) is 200 to 800.(4) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), and the molecular weight of the di(meth)acrylic monomer (B-2) is 170 to 700. (5) The (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), and the molecular weight of the tri(meth)acrylic monomer (B-3) is 200 to 1500. <6> The photocurable composition according to any one of <2> to <5>, wherein the molecular weight of the (meth)acrylic monomer (C) is 140 to 500. <7> The photocurable composition according to any one of <2> to <6>, wherein the content of the (meth)acrylic monomer (A) is 1% by mass to 20% by mass, based on the total amount of the (meth)acrylic monomer components. <8> The photocurable composition according to any one of <2> to <7>, wherein the content of the (meth)acrylic monomer (B) is 25% by mass to 90% by mass, based on the total amount of the (meth)acrylic monomer components. <9> The photocurable composition according to any one of <2> to <8>, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 70% by mass, based on the total amount of the (meth)acrylic monomer components. <10> The photocurable composition according to any one of <1> to <9>, wherein the photopolymerization initiator includes an acylphosphine oxide compound. <11> A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, wherein the photopolymerization initiator includes an acylphosphine oxide compound and an alkyl benzoylformate compound.<12> The photocurable composition according to <11>, wherein the photopolymerizable component comprises one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups, and a (meth)acrylic monomer (C) having one (meth)acryloyloxy group and having an aromatic structure. <13> The photocurable composition according to <12>, which satisfies at least one of the following (1) to (3): (1) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-1), and the molecular weight of the di(meth)acrylic monomer (B-1) is 200 to 800. (2) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), and the molecular weight of the di(meth)acrylic monomer (B-2) is 170 to 700. (3) The (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), and the molecular weight of the tri(meth)acrylic monomer (B-3) is 200 to 1500. <14> The photocurable composition according to <12> or <13>, wherein the molecular weight of the (meth)acrylic monomer (C) is 140 to 500. <15> The photocurable composition according to any one of <12> to <14>, wherein the content of the (meth)acrylic monomer (B) is 25% by mass to 95% by mass, based on the total amount of the (meth)acrylic monomer components. <16> The photocurable composition according to any one of <12> to <15>, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 75% by mass, based on the total amount of the (meth)acrylic monomer components. <17> The photocurable composition according to any one of <1> to <16>, wherein the viscosity, measured using an E-type viscometer at 25°C and 50 rpm, is 5 mPa s to 6,000 mPa s.<18> The photocurable composition according to any one of <1> to <17>, which is a photocurable composition for stereolithography. <19> The photocurable composition according to any one of <1> to <18>, which is used for producing a splint by stereolithography. <20> A three-dimensionally shaped object comprising a cured product of the photocurable composition according to any one of <1> to <19>. <21> A dental product comprising the three-dimensionally shaped object according to <20>. <22> A splint comprising the three-dimensionally shaped object according to <20>.
[0007] According to one aspect of the present disclosure, there are provided a photocurable composition capable of producing a cured product that combines high mechanical strength and high transparency, as well as a three-dimensionally shaped object, a dental product, and a splint that include a cured product of the photocurable composition.
[0008] In the present disclosure, a numerical range expressed using "to" means a range that includes the numerical values written before and after "to" as the lower and upper limits. In the present disclosure, when a composition contains multiple substances corresponding to each component, the amount of each component contained in the composition means the total amount of the multiple substances present in the composition, unless otherwise specified. In the numerical ranges described in stages in the present disclosure, the upper or lower limit described in one numerical range may be replaced with the upper or lower limit of another numerical range described in stages. Furthermore, in the numerical ranges described in the present disclosure, the upper or lower limit of that numerical range may be replaced with a value shown in the examples. In the present disclosure, "light" is a concept that includes active energy rays such as ultraviolet rays and visible light.
[0009] In this disclosure, "(meth)acrylate" means acrylate or methacrylate, "(meth)acryloyl" means acryloyl or methacryloyl, and "(meth)acrylic" means acrylic or methacrylic.
[0010] Hereinafter, the photocurable composition of the present disclosure will be described with reference to a first embodiment and a second embodiment. The configurations and preferred configurations of the first embodiment and the configurations and preferred configurations of the second embodiment may be combined as appropriate. In the second embodiment, the description of matters common to the first embodiment will be omitted.
[0011] [First Aspect] [Photocurable Composition] The photocurable composition of the first aspect is a photocurable composition containing a photopolymerizable component and a photopolymerization initiator, and is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm. 2 The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm. The object A1 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2 After irradiation, both sides of the 50 mm × 40 mm surface were polished to prepare a rectangular plate-shaped test piece A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm. * ab is 6.0 or less, and the photocurable composition is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm 2 The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm. The object A2 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2 When a rectangular plate-shaped test piece A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm was prepared by irradiating the composition, the test piece A2 had a bending strength of 50 MPa or more and a bending modulus of elasticity of 1500 MPa or more. By using the photocurable composition of the first aspect, it is possible to prepare a cured product that has both high mechanical strength and high transparency.
[0012] ΔE of test piece A1 * ab The lower limit of the bending strength of the test piece A2 is not particularly limited and may be, for example, 2.0 or more. The upper limit of the bending strength of the test piece A2 is not particularly limited and may be, for example, 90 MPa or less. The upper limit of the bending modulus of the test piece A2 is not particularly limited and may be, for example, 3000 MPa or less. The test pieces A1 and A2 may be prepared by the method described in the examples below.
[0013] The photocurable composition of the present disclosure is a composition that cures upon irradiation with light, and a cured product is obtained by curing this composition. A preferred method for producing a cured product using the photocurable composition of the present disclosure is stereolithography. The photocurable composition of the present disclosure is preferably a photocurable composition for stereolithography, and in other words, a cured product produced using the photocurable composition of the present disclosure is preferably a stereolithography product (i.e., a cured product obtained by stereolithography).
[0014] Stereolithography is a method of repeatedly irradiating a photocurable composition with light to form cured layers, thereby laminating the cured layers and obtaining a cured product (i.e., a stereolithography product). Stereolithography may be inkjet-type stereolithography or liquid-vat-type stereolithography (i.e., stereolithography using a liquid vat).
[0015] In inkjet stereolithography, droplets of a photocurable composition are ejected from an inkjet nozzle onto a substrate, and the droplets attached to the substrate are irradiated with light to obtain a cured product. In one example of inkjet stereolithography, for example, a head equipped with an inkjet nozzle and a light source is scanned within a plane while the photocurable composition is ejected from the inkjet nozzle onto the substrate, and the ejected photocurable composition is irradiated with light to form a cured layer. These operations are repeated to sequentially stack cured layers to obtain a cured product (i.e., a stereolithography product).
[0016] In liquid tank-type stereolithography, a portion of a photocurable composition (i.e., an uncured photocurable composition in a liquid state; the same applies hereinafter) contained in a liquid tank is cured by irradiating it with light to form a cured layer, and this operation is repeated to stack cured layers and obtain a cured product (i.e., a stereolithography product). Liquid tank-type stereolithography differs from inkjet-type stereolithography in that a liquid tank is used. Examples of liquid tank-type stereolithography include DLP (Digital Light Processing) stereolithography and SLA (Stereolithography) stereolithography. In the DLP method, planar light is irradiated onto the photocurable composition in the liquid tank. In the SLA method, laser light is scanned onto the photocurable composition in the liquid tank. From the viewpoint of more effectively achieving the effects of the photocurable composition of the present disclosure, DLP-type stereolithography is preferred as liquid tank-type stereolithography.
[0017] An example of DLP-based stereolithography uses a 3D printer (e.g., Kulzer's "Cara Print 4.0," Asiga's "Max UV," etc.) equipped with: a build table movable in the vertical direction; a tray (i.e., liquid tank) arranged below the build table (on the gravity side; the same applies below) that includes a light-transmitting portion and contains a photocurable composition; and a light source (e.g., an LED light source) arranged below the tray for irradiating the photocurable composition in the tray with planar light through the light-transmitting portion of the tray. In this example, first, a gap of one layer is formed between the build table and the tray, and this gap is filled with photocurable composition. Next, planar light is irradiated from below through the light-transmitting portion of the tray onto the photocurable composition filled in the gap, curing the irradiated area to form a first cured layer. Next, the gap between the build table and the tray is widened by the next layer, and the resulting space is filled with photocurable composition. Next, the photocurable composition filling the space is irradiated with light in the same manner as for curing the first layer, forming a second cured layer. By repeating the above operations, cured layers are stacked to produce a three-dimensional object. In this example, the three-dimensional object may be further cured by further irradiating the produced three-dimensional object with light. For details on DLP-based stereolithography, see, for example, Japanese Patent Publication No. 5111880 and Japanese Patent Publication No. 5235056.
[0018] <Applications> The application of the photocurable composition of the present disclosure is not particularly limited. The photocurable composition of the present disclosure may be a photocurable composition used in the production of dental products. Dental products produced using the photocurable composition have both high mechanical strength and high transparency. Examples of dental products include dental prostheses, medical instruments used in the oral cavity, dental models, and models for lost-beam casting. Examples of dental prostheses include inlays, crowns, bridges, temporary crowns, and temporary bridges. Examples of medical instruments used in the oral cavity include dentures (e.g., complete dentures, partial dentures, etc.), mouthpieces, mouthguards, orthodontic appliances, splints such as occlusal splints and splints for treating temporomandibular disorders, impression trays, and surgical guides. Examples of dental models include tooth and jaw models.
[0019] The photocurable composition of the present disclosure is preferably a photocurable composition for stereolithography, more preferably a photocurable composition used in the production of dental products by stereolithography, and even more preferably a photocurable composition used in the production of splints by stereolithography.
[0020] <Photopolymerizable Component> The photocurable composition of the present disclosure includes at least one photopolymerizable component. Examples of the photopolymerizable component include a compound containing an ethylenic double bond. Examples of the compound containing an ethylenic double bond include (meth)acrylic monomers, styrene, styrene derivatives, and (meth)acrylonitrile.
[0021] As the photopolymerizable component, the photopolymerizable components described in paragraphs 0030 to 0059 of WO 2019 / 189652 may be used.
[0022] From the viewpoint of mechanical strength of the cured product, the content of the photopolymerizable component relative to the total amount of the photocurable composition of the present disclosure is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more. The upper limit of the content of the photopolymerizable component relative to the total amount of the photocurable composition of the present disclosure is not particularly limited, and may be less than 100% by mass, for example, 99.9% by mass or less.
[0023] The photopolymerizable component preferably contains at least one (meth)acrylic monomer. Here, the (meth)acrylic monomer refers to a monomer having one or more (meth)acryloyl groups in the molecule. In the present disclosure, all (meth)acrylic monomers contained in the photocurable composition may be referred to as "(meth)acrylic monomer components," and the total content of all (meth)acrylic monomers contained in the photocurable composition of the present disclosure may be referred to as "total content of (meth)acrylic monomer components."
[0024] The total content of the (meth)acrylic monomer components relative to the total amount of photopolymerizable components in the photocurable composition of the first embodiment is preferably 80% by mass or more, more preferably 90% by mass or more, and even more preferably 95% by mass or more. The upper limit of the total content of the (meth)acrylic monomer components relative to the total amount of photopolymerizable components in the photocurable composition of the first embodiment is not particularly limited, as long as it is 100% by mass or less.
[0025] From the viewpoint of mechanical strength of the cured product, the total content of the (meth)acrylic monomer components relative to the total amount of the photocurable composition of the first aspect is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more. The upper limit of the total content of the (meth)acrylic monomer components relative to the total amount of the photocurable composition of the first aspect is not particularly limited, and may be less than 100% by mass, for example, 99.9% by mass or less.
[0026] The (meth)acrylic monomer constituting the (meth)acrylic monomer component is not particularly limited as long as it is a monomer having one or more (meth)acryloyloxy groups in the molecule. The (meth)acrylic monomer may be a monofunctional (meth)acrylic monomer (i.e., a monomer having one (meth)acryloyloxy group in the molecule), a bifunctional (meth)acrylic monomer (i.e., a monomer having two (meth)acryloyloxy groups in the molecule), or a polyfunctional (meth)acrylic monomer (i.e., a trifunctional or higher functional (meth)acrylic monomer; i.e., a monomer having three or more (meth)acryloyloxy groups in the molecule).
[0027] The photopolymerizable component comprises one or more (meth)acrylic monomers (A) selected from the group consisting of mono(meth)acrylic monomers (A-1) having one (meth)acryloyloxy group and no cyclic structure, and di(meth)acrylic monomers (A-2) having two (meth)acryloyloxy groups, no cyclic structure, and in which the distance between the oxygen atom forming the oxy group in one (meth)acryloyloxy group and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is 25 Å or more; The monomer may comprise one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups, and a (meth)acrylic monomer (C) having one (meth)acryloyloxy group and having an aromatic structure.
[0028] By using the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C), it is possible to suitably produce a cured product that has both high mechanical strength and high transparency. For example, by using the (meth)acrylic monomer (A), the transparency of the cured product tends to be increased, by using the (meth)acrylic monomer (B), the mechanical strength of the cured product tends to be increased, and by using the (meth)acrylic monomer (C), the transparency and mechanical strength of the cured product tend to be adjustable.
[0029] [(Meth)acrylic Monomer (A)] The (meth)acrylic monomer (A) includes one or more selected from the group consisting of the mono(meth)acrylic monomer (A-1) and the di(meth)acrylic monomer (A-2). The mono(meth)acrylic monomer (A-1) and the di(meth)acrylic monomer (A-2) may each independently be used alone or in combination of two or more.
[0030] (Mono(meth)acrylic Monomer (A-1)) The mono(meth)acrylic monomer (A-1) is a (meth)acrylic monomer component having one (meth)acryloyloxy group and no cyclic structure.
[0031] The mono(meth)acrylic monomer (A-1) does not contain a cyclic structure, and examples of the cyclic structure include an aromatic structure and an alicyclic structure.
[0032] The mono(meth)acrylic monomer (A-1) may contain a (meth)acrylic monomer component having one (meth)acryloyloxy group and a hydrocarbon group which may have a substituent. In the hydrocarbon group which may have a substituent, examples of the substituent include a hydroxy group, an amino group, a halogen atom (e.g., a fluorine atom, a chlorine atom, a bromine atom), a carbonyl group, a carboxy group, an ethyleneoxy group, and a propyleneoxy group.
[0033] The hydrocarbon group which may have a substituent may have 4 to 30 carbon atoms (excluding the carbon atoms of the substituent) or 5 to 20 carbon atoms or 6 to 18 carbon atoms.
[0034] The mono(meth)acrylic monomer (A-1) may contain one or more selected from the group consisting of a (meth)acrylic monomer component having one (meth)acryloyloxy group and a hydrocarbon group, and a (meth)acrylic monomer component having one (meth)acryloyloxy group and a hydroxy group. From the viewpoint of toughness of the cured product, it preferably contains a (meth)acrylic monomer component having one (meth)acryloyloxy group and a hydroxy group.
[0035] The molecular weight of the mono(meth)acrylic monomer (A-1) is preferably 100 to 500, more preferably 100 to 400, and even more preferably 100 to 300, from the viewpoint of mechanical strength of the cured product.
[0036] Examples of the mono(meth)acrylic monomer (A-1) include alkyl (meth)acrylates such as octyl (meth)acrylate, decyl (meth)acrylate, isodecyl (meth)acrylate, lauryl (meth)acrylate, and stearyl (meth)acrylate; hydroxyalkyl (meth)acrylates such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, and 4-hydroxybutyl (meth)acrylate; EO-modified or PO-modified (meth)acrylates such as methoxy-polyethylene glycol (meth)acrylate, ethoxy-polyethylene glycol (meth)acrylate, and methoxypolypropylene glycol (meth)acrylate; aminoalkyl (meth)acrylates such as dimethylaminoethyl (meth)acrylate and diethylaminoethyl (meth)acrylate; and halogenated alkyl (meth)acrylates such as chloroethyl (meth)acrylate and trifluoroethyl (meth)acrylate.
[0037] (Di(meth)acrylic Monomer (A-2)) The di(meth)acrylic monomer (A-2) is a (meth)acrylic monomer component having two (meth)acryloyloxy groups, not having a cyclic structure, and in which the distance (d1) between an oxygen atom forming an oxy group in one of the (meth)acryloyloxy groups and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is 25 Å or greater.
[0038] The di(meth)acrylic monomer (A-2) does not contain a cyclic structure, and examples of the cyclic structure include an aromatic structure and an alicyclic structure.
[0039] The di(meth)acrylic monomer (A-2) may have at least one of an ethyleneoxy group and a propyleneoxy group.
[0040] In the present disclosure, d1 (i.e., the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group) refers to the linear distance between these two oxygen atoms. d1 refers to the value determined using the "display distance measurement" function in "Chem 3D" (version 18.2.0.48) manufactured by PerkinElmer.
[0041] The d1 of the di(meth)acrylic monomer (A-2) is not particularly limited as long as it is 25 Å or more, and may be, for example, 30 Å or more, or 35 Å or more. The upper limit of d1 of the di(meth)acrylic monomer (A-2) is not particularly limited, and may be 50 Å or less.
[0042] The molecular weight of the di(meth)acrylic monomer (A-2) is preferably 400 to 1,000, more preferably 400 to 800, and even more preferably 400 to 700, from the viewpoint of transparency and mechanical strength of the cured product.
[0043] Examples of the di(meth)acrylic monomer (A-2) include polyethylene glycol di(meth)acrylate and polypropylene glycol di(meth)acrylate.
[0044] A higher content of (meth)acrylic monomer (A) tends to improve the transparency of the cured product, while a lower content of (meth)acrylic monomer (A) tends to improve the bending strength of the cured product. From the viewpoint of the balance between transparency and bending strength in the cured product, the content is preferably 1% by mass to 20% by mass, more preferably 3% by mass to 18% by mass, even more preferably 5% by mass to 17% by mass, and particularly preferably 10% by mass to 15% by mass, relative to the total amount of the (meth)acrylic monomer components. When the photocurable composition of the first aspect contains 4-hydroxybutyl (meth)acrylate as the mono(meth)acrylic monomer (A-1), from the viewpoint of the balance between transparency and bending strength in the cured product, the content of 4-hydroxybutyl (meth)acrylate is preferably 1% by mass to 20% by mass, more preferably 5% by mass to 17% by mass, and even more preferably 10% by mass to 15% by mass, relative to the total amount of the (meth)acrylic monomer components. Here, the content of the (meth)acrylic monomer (A) means the total content of the mono(meth)acrylic monomer (A-1) and the di(meth)acrylic monomer (A-2).
[0045] [(Meth)acrylic Monomer (B)] The (meth)acrylic monomer (B) includes one or more selected from the group consisting of the di(meth)acrylic monomer (B-1), the di(meth)acrylic monomer (B-2), and the tri(meth)acrylic monomer (B-3). The di(meth)acrylic monomer (B-1), the di(meth)acrylic monomer (B-2), and the tri(meth)acrylic monomer (B-3) may each independently be used alone or in combination of two or more.
[0046] (Di(meth)acrylic Monomer (B-1)) The di(meth)acrylic monomer (B-1) is a (meth)acrylic monomer component having two (meth)acryloyloxy groups and a cyclic structure.
[0047] Examples of the cyclic structure in the di(meth)acrylic monomer (B-1) include an aromatic structure, an alicyclic structure, etc. The cyclic structure also includes a combination of an aromatic structure with another linking group, such as a bisphenol A structure.
[0048] Examples of the aromatic structure include a benzene ring, a naphthalene ring, a bisphenol A structure, a phenylphenol structure, a phenoxybenzyl structure, a phenylalkylene structure, and an α-hydroxyphenyl structure.
[0049] Examples of the alicyclic structure include a cyclopropylene group, a cyclobutylene group, a cyclopentylene group, a cyclohexylene group, a cyclohexenylene group, a cycloheptylene group, a cyclooctylene group, a cyclononylene group, a cyclodecylene group, a cycloundecylene group, a cyclododecylene group, a cyclotridecylene group, a cyclotetradecylene group, a cyclopentadecylene group, a cyclooctadecylene group, a cycloicosylene group, a bicyclohexylene group, a norbornylene group, an isobornylene group, and an adamantylene group. Of these, a norbornylene group and an isobornylene group are preferred.
[0050] In the di(meth)acrylic monomer (B-1), the cyclic structure may be located in the main chain, or the cyclic structure may be located in a branched chain.
[0051] The di(meth)acrylic monomer (B-1) may contain one or more selected from the group consisting of (meth)acrylic monomer components containing a bisphenol A structure and (meth)acrylic monomer components containing a cyclic structure and a urethane bond. The di(meth)acrylic monomer (B-1) may have at least one of an ethyleneoxy group and a propyleneoxy group. For example, the (meth)acrylic monomer component containing a bisphenol A structure may have at least one of an ethyleneoxy group and a propyleneoxy group.
[0052] The molecular weight of the di(meth)acrylic monomer (B-1) is preferably 200 to 800, more preferably 300 to 700, and even more preferably 400 to 650, from the viewpoint of mechanical strength of the cured product.
[0053] The (meth)acrylic monomer component containing a cyclic structure and a urethane bond may contain a compound represented by the following formula (1).
[0054]
[0055] In formula (1), R 1 is a divalent chain hydrocarbon group, a divalent hydrocarbon group having an aromatic structure, or a divalent hydrocarbon group having an alicyclic structure, R 2 and R 3 are each independently a divalent chain hydrocarbon group which may have a substituent, and R 4 and R 5 are each independently a methyl group or a hydrogen atom. 1 is a divalent chain hydrocarbon group, R 2 and R 3 are each independently a divalent chain hydrocarbon group having an aromatic structure in the branched chain.
[0056] R in formula (1) 1 In the formula (R), the number of carbon atoms in the divalent chain hydrocarbon group is preferably 1 to 20, more preferably 1 to 10, and even more preferably 2 to 6. 1 The divalent chain hydrocarbon group in R may be linear or branched, may be saturated or unsaturated, and may have a substituent. 1 The divalent chain hydrocarbon group in is preferably a linear or branched alkylene group having 1 to 20 carbon atoms, more preferably a linear or branched alkylene group having 1 to 12 carbon atoms, and even more preferably a linear or branched alkylene group having 1 to 10 carbon atoms.
[0057] Specific examples of the linear or branched alkylene group having 1 to 20 carbon atoms include methylene, ethylene, propanediyl, butanediyl, pentanediyl, hexanediyl, heptanediyl, octanediyl, nonanediyl, decanediyl, undecanediyl, dodecanediyl, tridecanediyl, tetradecanediyl, pentadecanediyl, octadecanediyl, eicosylene, vinylene, propenediyl, butenediyl, pentenediyl, ethynylene, propynylene, and 2,4,4-trimethylhexylene. Of these, hexanediyl and 2,4,4-trimethylhexylene are preferred.
[0058] R in formula (1) 1 In the above, the divalent hydrocarbon group having an aromatic structure is preferably a divalent hydrocarbon group having an aromatic structure of 6 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 10 carbon atoms) which may have a substituent. Examples of the divalent hydrocarbon group having an aromatic structure include an arylene group, an alkylenearylene group, an alkylenearylenealkylene group, and an arylenealkylenearylene group. The divalent hydrocarbon group having an aromatic structure is preferably an alkylenearylene group or an alkylenearylenealkylene group.
[0059] Specific examples of the arylene group, alkylenearylene group, alkylenearylenealkylene group, alkylarylene group and arylenealkylenearylene group include a 1,3- or 1,4-phenylene group, a 1,3- or 1,4-phenylenedimethylene group, and a 1,3- or 1,4-phenylenediethylene group.
[0060] R in formula (1) 1 In the formula (I), the divalent hydrocarbon group having an alicyclic structure preferably has 3 to 20 carbon atoms, more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms. Specific examples of the alicyclic structure are as described above.
[0061] R 1When is a divalent hydrocarbon group having an alicyclic structure, particularly preferred examples are as follows: * represents the bonding position.
[0062]
[0063] R in formula (1) 1 The divalent hydrocarbon group having an alicyclic structure in the formula (I) may have a substituent, such as a linear or branched alkyl group having 1 to 6 carbon atoms.
[0064] In formula (1), R 2 and R 3 R are each independently a divalent chain hydrocarbon group which may have a substituent. 2 and R 3 A divalent chain hydrocarbon group suitable as R 1 The divalent chain hydrocarbon groups are the same as those suitable for R 2 and R 3 The optionally substituted divalent chain hydrocarbon group in the formula (I) preferably has 2 to 6 carbon atoms, and more preferably 2 to 3 carbon atoms.
[0065] R 2 and R 3 When is a substituted divalent chain hydrocarbon group, examples of the substituent include: alkyl groups having 1 to 6 carbon atoms, such as a methyl group or an ethyl group; aryl groups; cycloalkyl groups having 3 to 6 carbon atoms, such as a cyclopentyl group or a cyclohexyl group; tolyl groups; xylyl groups; cumyl groups; styryl groups; alkoxyphenyl groups, such as a methoxyphenyl group, an ethoxyphenyl group or a propoxyphenyl group; and phenoxyalkyl groups, such as a phenoxymethyl group, a phenoxyethyl group or a phenoxypropyl group.
[0066] R 1 is a divalent chain hydrocarbon group, R 2 and R 3 are each independently a divalent chain hydrocarbon group having an aromatic structure in the branched chain, and are preferably a divalent chain hydrocarbon group having the above-mentioned alkoxyphenyl group or phenoxyalkyl group in the branched chain.
[0067] (Di(meth)acrylic Monomer (B-2)) The di(meth)acrylic monomer (B-2) is a (meth)acrylic monomer component (excluding the di(meth)acrylic monomer (B-1)) that has two (meth)acryloyloxy groups, in which the distance (d1) between the oxygen atom forming the oxy group in one of the (meth)acryloyloxy groups and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å.
[0068] The d1 of the di(meth)acrylic monomer (B-2) may be 3.0 Å or more, 5.0 Å or more, or 10 Å or more. The upper limit of the d1 of the di(meth)acrylic monomer (B-2) may be less than 25 Å and 23 Å or less.
[0069] The molecular weight of the di(meth)acrylic monomer (B-2) is preferably 170 to 700, more preferably 200 to 600, and even more preferably 250 to 500, from the viewpoint of transparency of the cured product.
[0070] The di(meth)acrylic monomer (B-2) may contain one or more selected from the group consisting of (meth)acrylic monomer components having at least one of an ethyleneoxy group and a propyleneoxy group, and (meth)acrylic monomer components containing a urethane bond. The di(meth)acrylic monomer (B-2) preferably does not contain a cyclic structure.
[0071] Examples of the (meth)acrylic monomer component having at least one of an ethyleneoxy group and a propyleneoxy group include diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, EO-modified neopentyl glycol di(meth)acrylate, PO-modified neopentyl glycol di(meth)acrylate, EO-modified hexanediol di(meth)acrylate, and PO-modified hexanediol di(meth)acrylate.
[0072] Examples of the (meth)acrylic monomer component containing a urethane bond include compounds represented by the following formula (2).
[0073]
[0074] In formula (1), R 6 is a divalent chain hydrocarbon group, R 7 and R 8 are each independently a divalent chain hydrocarbon group which may have a substituent, and R 9 and R 10 are each independently a methyl group or a hydrogen atom.
[0075] R in formula (2) 6 A preferred embodiment of the divalent chain hydrocarbon group in formula (1) is 1 The preferred embodiments of the divalent chain hydrocarbon group in formula (2) are the same as those in formula (2). 7 and R 8 A preferred embodiment of the optionally substituted divalent chain hydrocarbon group in formula (1) is 2 and R 3 The preferred embodiments are the same as those of the divalent chain hydrocarbon group which may have a substituent in the above (excluding the case where a cyclic structure is contained).
[0076] Examples of the (meth)acrylic monomer component containing a urethane bond include 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (UDMA) and 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)diacrylate (UDA1).
[0077] (Tri(meth)acrylic Monomer (B-3)) The tri(meth)acrylic monomer (B-3) is a (meth)acrylic monomer component having three (meth)acryloyloxy groups.
[0078] The molecular weight of the tri(meth)acrylic monomer (B-3) is preferably 200 to 1,500, more preferably 250 to 1,000, and even more preferably 300 to 800, from the viewpoint of transparency of the cured product.
[0079] Examples of the tri(meth)acrylic monomer (B-3) include trimethylolpropane tri(meth)acrylate, trifunctional urethane (meth)acrylate, ethoxylated trimethylolpropane triacrylate (EO=3 mol), propoxylated trimethylolpropane triacrylate (PO=3 mol), propoxylated glycerin triacrylate (PO=3 mol), and caprolactone-modified tris-(2-acryloxyethyl)isocyanurate.
[0080] The content of the (meth)acrylic monomer (B) is preferably 25% by mass to 90% by mass, more preferably 30% by mass to 85% by mass, even more preferably 35% by mass to 80% by mass, and particularly preferably 40% by mass to 75% by mass, based on the total amount of the (meth)acrylic monomer components. Here, the content of the (meth)acrylic monomer (B) means the total content of the di(meth)acrylic monomer (B-1), di(meth)acrylic monomer (B-2), and tri(meth)acrylic monomer (B-3).
[0081] When the (meth)acrylic monomer (B) contains a di(meth)acrylic monomer (B-1), the content of the di(meth)acrylic monomer (B-1) may be 25% by mass to 90% by mass, or 40% by mass to 80% by mass, based on the total amount of the (meth)acrylic monomer components.
[0082] When the (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), the content of the di(meth)acrylic monomer (B-2) may be 5% by mass to 90% by mass, 5% by mass to 20% by mass, or 40% by mass to 80% by mass, based on the total amount of the (meth)acrylic monomer components.
[0083] When the (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), the content of the tri(meth)acrylic monomer (B-3) may be 5% by mass to 70% by mass, or 10% by mass to 60% by mass, based on the total amount of the (meth)acrylic monomer components.
[0084] [(Meth)acrylic Monomer (C)] The (meth)acrylic monomer (C) contains a (meth)acrylic monomer component having one (meth)acryloyloxy group and an aromatic structure. The (meth)acrylic monomer (C) may be used alone or in combination of two or more.
[0085] The molecular weight of the (meth)acrylic monomer (C) is preferably 140 to 500, more preferably 140 to 400, and even more preferably 140 to 300.
[0086] The (meth)acrylic monomer (C) may be a compound represented by the following formula (3).
[0087]
[0088] In formula (3), R 11 is a monovalent organic group having an aromatic structure.
[0089] R in formula (3) 11 The monovalent organic group having an aromatic structure in the formula (I) is preferably a monovalent organic group having 3 to 30 carbon atoms, and more preferably a monovalent organic group having 6 to 20 carbon atoms.
[0090] In formula (3), R 11 may be an organic group represented by the following formula (4):
[0091]
[0092] In formula (4), L 1 represents a single bond or a divalent chain hydrocarbon group having 1 to 30 carbon atoms which may have a heteroatom which is O or N, and A represents an aryl group having 6 to 30 carbon atoms. * represents the bonding position.
[0093] In formula (4), L 1 The divalent chain hydrocarbon group having 1 to 30 carbon atoms and optionally having a heteroatom of O or N, represented by the formula (I), may be linear or branched. 1The number of carbon atoms in the divalent chain hydrocarbon group having 1 to 30 carbon atoms and optionally having a heteroatom of O or N, represented by the formula (I), is more preferably 1 to 20, even more preferably 1 to 10, and particularly preferably 1 to 8. 1 When the divalent chain hydrocarbon group represented by the formula 1 The number of heteroatoms therein is preferably 1 to 3, and more preferably 1 or 2.
[0094] L 1 The divalent chain hydrocarbon group represented by the formula (I) may have a substituent. Suitable examples of the substituent include an alkyl group having 1 to 3 carbon atoms, a hydroxy group, and an alkyl group having 1 to 3 carbon atoms in which one or two hydrogen atoms are substituted with a hydroxy group. 1 The divalent chain hydrocarbon group represented by the formula (I) may contain a urethane bond. 1 When the divalent chain hydrocarbon group represented by the formula (I) contains a urethane bond, L 1 The number of urethane bonds therein may be one or two.
[0095] L in formula (4) 1 Specific examples of the divalent chain hydrocarbon group represented by the formula include the following groups: In the following groups, * indicates the bonding position.
[0096] In formula (4), examples of the aromatic structure in the aryl group having 6 to 30 carbon atoms represented by A include a phenyl structure, a biphenyl structure, a naphthyl structure, and an anthryl structure.
[0097] The group represented by A in formula (4) may have a substituent. Suitable examples of the substituent include: alkyl groups having 1 to 6 carbon atoms, such as a methyl group or an ethyl group; a hydroxy group; an alkyl group having 1 to 6 carbon atoms substituted with one or two hydroxy groups; an aryl group; a cycloalkyl group having 3 to 6 carbon atoms, such as a cyclopentyl group or a cyclohexyl group; a tolyl group; a xylyl group; a cumyl group; a styryl group; an alkoxyphenyl group, such as a methoxyphenyl group, an ethoxyphenyl group, or a propoxyphenyl group; and phenoxyalkyl groups, such as a phenoxymethyl group, a phenoxyethyl group, or a phenoxypropyl group.
[0098] Examples of the group represented by A in formula (4) include the following: * represents a bonding position.
[0099]
[0100] The content of the (meth)acrylic monomer (C) is preferably 5% by mass to 70% by mass, more preferably 8% by mass to 60% by mass, even more preferably 10% by mass to 55% by mass, and particularly preferably 12% by mass to 50% by mass, based on the total amount of the (meth)acrylic monomer components.
[0101] The total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C) is preferably 50% by mass to 100% by mass, more preferably 70% by mass to 100% by mass, and even more preferably 90% by mass to 100% by mass, based on the total amount of the (meth)acrylic monomer components.
[0102] [Photopolymerization initiator] The photocurable composition of the first embodiment contains a photopolymerization initiator. The photocurable composition of the first embodiment may contain only one type of photopolymerization initiator, or may contain two or more types of photopolymerization initiators.
[0103] The photopolymerization initiator is not particularly limited as long as it generates radicals upon irradiation with light, and is preferably one that generates radicals at the wavelength of light used in stereolithography. The wavelength of light used in stereolithography is generally 365 nm to 500 nm, but in practice it is preferably 365 nm to 430 nm, and more preferably 365 nm to 420 nm.
[0104] Examples of photopolymerization initiators include acylphosphine oxide compounds, alkyl benzoyl formates, alkylphenone compounds, titanocene compounds, oxime ester compounds, benzoin compounds, acetophenone compounds, benzophenone compounds, thioxanthone compounds, α-acyloxime ester compounds, phenyl glyoxylate compounds, benzyl compounds, azo compounds, diphenyl sulfide compounds, organic dye compounds, iron-phthalocyanine compounds, benzoin ether compounds, and anthraquinone compounds. The photopolymerization initiator preferably contains at least one of an acylphosphine oxide compound and an alkyl benzoyl formate compound, and more preferably contains an acylphosphine oxide compound. Two or more photopolymerization initiators may be combined, and from the viewpoint of transparency of the cured product, the photopolymerization initiator may contain an acylphosphine oxide compound and an alkyl benzoyl formate compound.
[0105] Examples of the acylphosphine oxide compounds include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, and bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide.
[0106] Examples of the alkyl benzoylformate include methyl benzoylformate, ethyl benzoylformate, propyl benzoylformate, and butyl benzoylformate.
[0107] The total content of the photopolymerization initiator in the photocurable composition of the first aspect is preferably 0.1% by mass to 5% by mass, more preferably 0.5% by mass to 4% by mass, and even more preferably 0.5% by mass to 3% by mass, relative to the total amount of the photocurable composition.
[0108] When the photopolymerization initiator contains an acylphosphine oxide-based compound, the content of the acylphosphine oxide-based compound may be 50% by mass to 100% by mass, 70% by mass to 100% by mass, or 90% by mass to 100% by mass, relative to the total amount of the photopolymerization initiator.
[0109] When the photopolymerization initiator contains 2,4,6-trimethylbenzoyldiphenylphosphine oxide, the content of 2,4,6-trimethylbenzoyldiphenylphosphine oxide is preferably 1% by mass to 5% by mass, and more preferably 1.5% by mass to 3% by mass, relative to the total amount of the photocurable composition.
[0110] When the photopolymerization initiator contains bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, the content of bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide is preferably 0.1% by mass to 2% by mass, and more preferably 0.5% by mass to 1% by mass, relative to the total amount of the photocurable composition.
[0111] <Other Components> The photocurable composition of the first embodiment may contain one or more components other than the above-described components, as necessary. The total mass of the photopolymerizable component and the photopolymerization initiator in the photocurable composition is preferably 30% by mass or more, more preferably 50% by mass or more, even more preferably 70% by mass or more, even more preferably 80% by mass or more, and even more preferably 90% by mass or more, based on the total amount of the photocurable composition. The upper limit of the total mass of the photopolymerizable component and the photopolymerization initiator is not particularly limited, and may be 100% by mass or less, for example, 99.9% by mass or less.
[0112] The photocurable composition may contain monomers other than the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C), components other than the monomers and the photopolymerization initiator, etc. (hereinafter also referred to as "other components"). When the photocurable composition contains monomers other than the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C) as other components, the content of the monomers as other components is preferably 50% by mass or less, more preferably 30% by mass or less, even more preferably 20% by mass or less, and particularly preferably 10% by mass or less, based on the total mass of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C).
[0113] Examples of other components include coloring materials, coupling agents such as silane coupling agents (e.g., 3-acryloxypropyltrimethoxysilane), additives such as rubber agents, ion trapping agents, ion exchange agents, leveling agents, plasticizers, and antifoaming agents, and thermal polymerization initiators. When the photocurable composition of the first aspect contains a thermal polymerization initiator, photocuring and thermal curing can be performed in combination. Examples of thermal polymerization initiators include thermal radical generators and amine compounds.
[0114] However, from the viewpoint of further improving the molding accuracy of the cured product, the photocurable composition of the first aspect does not contain an inorganic filler (e.g., silica, barium borosilicate glass, etc.; the same applies hereinafter), or if it contains an inorganic filler, the content of the inorganic filler relative to the total amount of the photocurable composition is preferably 60% by mass or less (more preferably 40% by mass or less, even more preferably 20% by mass or less, and particularly preferably 10% by mass or less).
[0115] [Variation of First Aspect] A photocurable composition according to a variation of the first aspect is a photocurable composition containing a photopolymerizable component and a photopolymerization initiator, wherein the photopolymerizable component includes: one or more (meth)acrylic monomers (A) selected from the group consisting of mono(meth)acrylic monomer (A-1) and di(meth)acrylic monomer (A-2); one or more (meth)acrylic monomers (B) selected from the group consisting of di(meth)acrylic monomer (B-1), di(meth)acrylic monomer (B-2) (excluding di(meth)acrylic monomer (B-1)), and tri(meth)acrylic monomer (B-3); and a (meth)acrylic monomer (C). Use of the photocurable composition according to a variation of the first aspect makes it possible to produce a cured product that exhibits both high mechanical strength and high transparency. Furthermore, the photocurable composition according to this variation may or may not satisfy the condition that the ΔE*ab of test piece A1 is 6.0 or less. The photocurable composition according to this modification may or may not satisfy the condition that the flexural strength of the test piece A2 is 50 MPa or more. The photocurable composition according to this modification may or may not satisfy the condition that the flexural modulus of the test piece A2 is 1500 MPa or more.
[0116] [Second Aspect] [Photocurable Composition] The photocurable composition of the second aspect is a photocurable composition containing a photopolymerizable component and a photopolymerization initiator, wherein the photopolymerization initiator contains an acylphosphine oxide compound and an alkyl benzoylformate compound. By containing the photopolymerizable component and the photopolymerization initiator containing the acylphosphine oxide compound and the alkyl benzoylformate compound, the photocurable composition of the second aspect can produce a cured product that has both high mechanical strength and high transparency.
[0117] From the viewpoint of mechanical strength of the cured product, the photopolymerizable component in the second aspect preferably contains one or more (meth)acrylic monomers (B) selected from the group consisting of di(meth)acrylic monomer (B-1), di(meth)acrylic monomer (B-2) (excluding di(meth)acrylic monomer (B-1)), and tri(meth)acrylic monomer (B-3); and a (meth)acrylic monomer (C).
[0118] The di(meth)acrylic monomer (B-1) is the same as the di(meth)acrylic monomer (B-1) used in the first embodiment described above. The di(meth)acrylic monomer (B-2) is the same as the di(meth)acrylic monomer (B-2) used in the first embodiment described above. The tri(meth)acrylic monomer (B-3) is the same as the tri(meth)acrylic monomer (B-3) used in the first embodiment described above. The (meth)acrylic monomer (C) is the same as the (meth)acrylic monomer (C) used in the first embodiment described above.
[0119] The content of the (meth)acrylic monomer (B) is preferably 25% by mass to 95% by mass, more preferably 30% by mass to 90% by mass, even more preferably 40% by mass to 90% by mass, and particularly preferably 50% by mass to 85% by mass, based on the total amount of the (meth)acrylic monomer components. Here, the content of the (meth)acrylic monomer (B) means the total content of the di(meth)acrylic monomer (B-1), di(meth)acrylic monomer (B-2), and tri(meth)acrylic monomer (B-3).
[0120] When the (meth)acrylic monomer (B) contains a di(meth)acrylic monomer (B-1), the content of the di(meth)acrylic monomer (B-1) may be 25% by mass to 95% by mass, or 50% by mass to 90% by mass, based on the total amount of the (meth)acrylic monomer components.
[0121] When the (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), the content of the di(meth)acrylic monomer (B-2) may be 10% by mass to 95% by mass, 10% by mass to 30% by mass, or 50% by mass to 90% by mass, based on the total amount of the (meth)acrylic monomer components.
[0122] When the (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), the content of the tri(meth)acrylic monomer (B-3) may be 5% by mass to 70% by mass, or 10% by mass to 60% by mass, based on the total amount of the (meth)acrylic monomer components.
[0123] The content of the (meth)acrylic monomer (C) is preferably 5% by mass to 75% by mass, more preferably 10% by mass to 70% by mass, even more preferably 10% by mass to 60% by mass, and particularly preferably 15% by mass to 50% by mass, based on the total amount of the (meth)acrylic monomer components.
[0124] The total content of the (meth)acrylic monomer (B) and the (meth)acrylic monomer (C) relative to the total amount of photopolymerizable components in the photocurable composition of the second aspect is preferably 80% by mass or more, more preferably 90% by mass or more, and even more preferably 95% by mass or more. The upper limit of the total content of the (meth)acrylic monomer (B) and the (meth)acrylic monomer (C) relative to the total amount of photopolymerizable components in the photocurable composition of the second aspect is not particularly limited, and may be 100% by mass or less.
[0125] [Photopolymerization initiator] The photocurable composition of the second embodiment contains a photopolymerization initiator. The photopolymerization initiator contains an acylphosphine oxide compound and an alkyl benzoylformate compound. The photopolymerization initiator, such as an acylphosphine oxide compound or an alkyl benzoylformate compound, is not particularly limited as long as it generates radicals upon irradiation with light, and is preferably one that generates radicals at the wavelength of light used in stereolithography. Preferred examples of the acylphosphine oxide compound and the alkyl benzoylformate compound are the same as those described in the first embodiment. The photocurable composition of the second embodiment may independently contain only one type of acylphosphine oxide compound and one type of alkyl benzoylformate compound, or may contain two or more types.
[0126] The photocurable composition of the second embodiment may contain a photopolymerization initiator other than an acylphosphine oxide compound and an alkyl benzoylformate compound (hereinafter also referred to as "other photopolymerization initiators"). Examples of other photopolymerization initiators include alkylphenone compounds, titanocene compounds, oxime ester compounds, benzoin compounds, acetophenone compounds, benzophenone compounds, thioxanthone compounds, α-acyloxime ester compounds, phenyl glyoxylate compounds, benzyl compounds, azo compounds, diphenyl sulfide compounds, organic dye compounds, iron phthalocyanine compounds, benzoin ether compounds, and anthraquinone compounds.
[0127] The total content of the photopolymerization initiator in the photocurable composition of the second aspect is preferably 0.1% by mass to 10% by mass, more preferably 0.5% by mass to 8% by mass, and even more preferably 1% by mass to 5% by mass, relative to the total amount of the photocurable composition.
[0128] The total content of the acylphosphine oxide compound and the alkyl benzoylformate compound may be 50% by mass to 100% by mass, 70% by mass to 100% by mass, or 90% by mass to 100% by mass, based on the total amount of the photopolymerization initiator.
[0129] The mass ratio of the acylphosphine oxide compound to the alkyl benzoylformate compound (acylphosphine oxide compound:alkyl benzoylformate compound) may be 1:0.1 to 1:10, 1:0.2 to 1:5, or 1:0.25 to 1:2.
[0130] <Other Components> The photocurable composition of the second embodiment may contain one or more components other than the above-mentioned components, as necessary. When the photocurable composition contains other components, the total mass of the (meth)acrylic monomer (B), the (meth)acrylic monomer (C), and the photopolymerization initiator is preferably 30% by mass or more, more preferably 50% by mass or more, even more preferably 70% by mass or more, even more preferably 80% by mass or more, and even more preferably 90% by mass or more, based on the total amount of the photocurable composition. The upper limit of the total mass of the (meth)acrylic monomer (B), the (meth)acrylic monomer (C), and the photopolymerization initiator is not particularly limited, and may be 100% by mass or less, for example, 99.9% by mass or less.
[0131] Examples of other components include monomers other than the (meth)acrylic monomer (B) and the (meth)acrylic monomer (C). When the photocurable composition contains a monomer other than the (meth)acrylic monomer (B) and the (meth)acrylic monomer (C) as other components, the content of the monomer as the other component is preferably 50% by mass or less, more preferably 30% by mass or less, even more preferably 20% by mass or less, and particularly preferably 10% by mass or less, based on the total mass of the (meth)acrylic monomer (B) and the (meth)acrylic monomer (C).
[0132] The photocurable composition of the second embodiment is prepared by irradiating the photocurable composition with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm. 2The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm. The object A1 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2 After irradiation, both sides of the 50 mm × 40 mm surface were polished to prepare a rectangular plate-shaped test piece A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm. * ab may be 6.0 or less.
[0133] The photocurable composition of the second embodiment is prepared by irradiating the photocurable composition with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ / cm. 2 The cured layers A1 were laminated in the thickness direction to form a rectangular plate-shaped object A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm. The object A2 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2 The photocurable composition may be such that, when a rectangular plate-shaped test piece A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm is prepared by irradiating the photocurable composition, the test piece A2 has a bending strength of 50 MPa or more and a bending modulus of elasticity of 1500 MPa or more.
[0134] The photocurable composition of the second embodiment has the above-mentioned ΔE * ab At least one of the numerical conditions of bending strength and bending modulus may be satisfied, and preferably all of the numerical conditions may be satisfied.
[0135] ΔE of test piece A1 * ab The lower limit of the bending strength of the test piece A2 is not particularly limited and may be, for example, 2.0 or more. The upper limit of the bending modulus of the test piece A2 is not particularly limited and may be, for example, 90 MPa or less. The upper limit of the bending modulus of the test piece A2 is not particularly limited and may be, for example, 3000 MPa or less.
[0136] The method for preparing the photocurable composition of the present disclosure is not particularly limited. Examples of methods for preparing the photocurable composition of the present disclosure include a method of mixing a photopolymerizable component, a photopolymerization initiator, and, if necessary, other components. The means for mixing the components is not particularly limited, and includes, for example, ultrasonic dissolution, a twin-arm mixer, a roll mixer, a twin-screw extruder, a ball mill mixer, and a planetary mixer. The photocurable composition of the present embodiment may be prepared by mixing the components, filtering the mixture through a filter to remove impurities, and then subjecting the mixture to a vacuum degassing treatment.
[0137] <Preferred Viscosity of Photocurable Composition> The photocurable composition of the present disclosure preferably has a viscosity (hereinafter also simply referred to as "viscosity") measured at 25°C and 50 rpm using an E-type viscometer of 5 mPa·s to 6000 mPa·s. Here, rpm means revolutions per minute (revolutions per minute). When the viscosity is 5 mPa·s to 6000 mPa·s, the photocurable composition exhibits excellent handleability when producing a cured product (particularly a stereolithography product). The viscosity is more preferably 10 mPa·s to 5000 mPa·s, even more preferably 20 mPa·s to 5000 mPa·s, and even more preferably 100 mPa·s to 4500 mPa·s.
[0138] [Three-dimensionally shaped object] The three-dimensionally shaped object of the present disclosure includes a cured product of the photocurable composition of the present disclosure. Therefore, the three-dimensionally shaped object of the present disclosure has both high mechanical strength and high transparency. The three-dimensionally shaped object of the present disclosure preferably includes a cured product obtained by stereolithography (i.e., a stereolithography object). The method for producing the cured product (e.g., a stereolithography object) is as described above.
[0139] [Dental Product] The dental product of the present disclosure includes the three-dimensionally shaped object of the present disclosure. Therefore, the dental product of the present disclosure has both high mechanical strength and high transparency. Specific examples of the dental product are as described above, and one example is a splint.
[0140] Examples of the present disclosure will be described below, but the present disclosure is not limited to the following examples.
[0141] Examples 1A to 20A, Comparative Examples 1A to 10A Preparation of Photocurable Compositions The components shown in Tables 1 to 3 were mixed to obtain photocurable compositions.
[0142] <Measurements and Evaluations> The photocurable compositions obtained were subjected to the following measurements and evaluations. The results are shown in Tables 1 to 3.
[0143] (ΔE * ab Measurement of ΔE of the cured products obtained using the photocurable compositions prepared in each Example and Comparative Example * ab was measured by the following method. The results are shown in Tables 1 to 3. Using a 3D printer (Kulzer, Cara Print 4.0), a test piece of 50 mm × 40 mm × 4.5 mm was prepared using the photocurable composition to be measured, with a layer width of 50 μm, and visible light with a wavelength of 405 nm was applied to each layer at 11 mJ / cm. 2 The obtained test piece was irradiated with ultraviolet light of 365 nm wavelength at 10 J / cm 2 The photocurable composition was fully cured by irradiation under the conditions of (a) to (c), thereby obtaining a cured product of the test piece. The cured test piece obtained was polished on both sides of a 50 mm × 40 mm surface using a rotary polisher (Ecomet 30, manufactured by Buhler) at 150 rpm, using 400-grit abrasive paper on one side to polish 0.15 mm, 800-grit abrasive paper on one side to polish 0.07 mm, 1000-grit abrasive paper on one side to polish 0.02 mm, and 2000-grit abrasive paper on one side to polish 0.01 mm, for a total of 0.25 mm (total polishing of 0.50 mm on both sides). Both sides were then polished using Polishing Cloth (MasterTex Polishing Cloth 40-7742, manufactured by Buhler) and 1 g of abrasive (high-purity alumina powder, particle size 1 μm, manufactured by Sankei Co., Ltd.) for 15 seconds on each side, to obtain a polished test piece measuring 50 mm × 40 mm × 4.0 mm. Using a color difference meter (SD3000, manufactured by Nippon Denshoku Industries Co., Ltd.), the L of a 50 mm x 40 mm surface was measured. * a * b *The measurement was performed in a transmission mode using the attached standard white plate (SCI X: 94.25, Y: 99.44, Z: 106.37) as a reference. * = 96.98, a * = -0.24, b * = 0.05; color values based on "SCI X: 94.25, Y: 99.44, Z: 106.37" as a reference) * a * b * is used as the reference color, and ΔE * ab = (ΔL 2 +Δa 2 +Δb 2 ) 1/2 In the calculation formula, ΔE * ab was calculated.
[0144] (Measurement of flexural strength and flexural modulus) The flexural strength and flexural modulus of the cured products obtained using the photocurable compositions prepared in each Example and Comparative Example were measured by the following method. Using a 3D printer (Kulzer, Cara Print 4.0), a test piece of 64 mm × 10 mm × 3.3 mm was printed using the photocurable composition to be measured, with a layer width of 50 μm, and visible light of 405 nm wavelength was applied to each layer at 11 mJ / cm. 2 The obtained test piece was irradiated with ultraviolet light of 365 nm wavelength at 10 J / cm 2 The curable composition was fully cured by irradiation under the conditions of
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
[0059]
[0061]
[0059]
[0062]
[0059]
[0059]
[0063]
[0059]
[0059]
[0064]
[0059]
[0065]
[0066]
[0059]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0100]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099]
[0099] [0100
[0145]
[0146]
[0147]
[0148] In Tables 1 to 3, the numbers in the "Composition" column for each Example and Comparative Example mean parts by mass, and blank spaces mean that the corresponding component is not contained.
[0149] <(Meth)acrylic Monomer (A)> In Tables 1 to 3, compounds classified as (meth)acrylic monomer (A) are specifically photopolymerizable components 1 to 7 below. Of photopolymerizable components 1 to 7, photopolymerizable components 1 to 5 have one (meth)acryloyloxy group and are classified as mono(meth)acrylic monomers (A-1) that do not have a cyclic structure. Of photopolymerizable components 1 to 7, photopolymerizable components 6 and 7 have two (meth)acryloyloxy groups, do not have a cyclic structure, and are classified as di(meth)acrylic monomers (A-2) that have a distance of 25 Å or more between the oxygen atom forming the oxy group in one (meth)acryloyloxy group and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group.
[0150] Photopolymerizable component 1: 2-hydroxyethyl methacrylate (HO-250, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 2: 2-hydroxypropyl methacrylate (HOP(N), Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 3: 2-hydroxypropyl acrylate (HOP-A(N), Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 4: 4-hydroxybutyl acrylate (4HBA, Osaka Organic Chemical Industry Ltd.) Photopolymerizable component 5: lauryl acrylate (LA, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 6: polyethylene glycol (400) diacrylate (FA240A, Showa Denko Materials K.K., d1=31.6 Å) Photopolymerizable component 7: polypropylene glycol (700) diacrylate (APG-700, Shin-Nakamura Chemical Co., Ltd., d1=42.1 Å)
[0151]
[0152]
[0153] <(Meth)acrylic Monomer (B)> In Tables 1 to 3, compounds classified as (meth)acrylic monomer (B) are specifically photopolymerizable components 8 to 17 shown below. Of photopolymerizable components 8 to 17, photopolymerizable components 8 to 10, 13, and 14 have two (meth)acryloyloxy groups and are classified as di(meth)acrylic monomers (B-1) having a cyclic structure. Of photopolymerizable components 8 to 17, photopolymerizable components 11, 12, and 15 to 17 have two (meth)acryloyloxy groups and are classified as di(meth)acrylic monomers (B-2) (excluding di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups, in which the distance between the oxygen atom forming the oxy group in one (meth)acryloyloxy group and the oxygen atom forming the oxy group in the other (meth)acryloyloxy group is less than 25 Å.
[0154] Photopolymerizable component 8: ethoxylated bisphenol A diacrylate (ABE-300, Shin-Nakamura Chemical Co., Ltd.) Photopolymerizable component 9: ethoxylated bisphenol A diacrylate (A-BPE-4, Shin-Nakamura Chemical Co., Ltd.) Photopolymerizable component 10: ethoxylated bisphenol A dimethacrylate (SR540, Sartomer Corporation) Photopolymerizable component 11: urethane diacrylate (UDA1, compound produced according to Production Example 1 below, d1=20.3 Å) Photopolymerizable component 12: urethane dimethacrylate (UDMA, Fujifilm Wako Pure Chemical Industries, Ltd., d1=20.3 Å) Photopolymerizable component 13: bifunctional urethane acrylate (AH-600, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 14: bifunctional urethane acrylate (UDA2, compound produced according to Production Example 2 below) Photopolymerizable component 15: tetraethylene glycol dimethacrylate (4EG, Kyoeisha Chemical Co., Ltd., d1 = 14.1 Å) Photopolymerizable component 16: triethylene glycol diacrylate (3EG-A, Kyoeisha Chemical Co., Ltd., d1 = 10.6 Å) Photopolymerizable component 17: tetraethylene glycol diacrylate (4EG-A, Kyoeisha Chemical Co., Ltd., d1 = 14.1 Å)
[0155]
[0156]
[0157] <(Meth)acrylic Monomer (C)> In Tables 1 to 3, compounds classified as (meth)acrylic monomer (C) are specifically the following photopolymerizable components 18 to 23.
[0158] Photopolymerizable component 18: benzyl methacrylate (BZ, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 19: phenoxyethyl methacrylate (PO, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 20: phenoxyethyl acrylate (PO-A, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 21: m-phenoxybenzyl acrylate (POB-A, Kyoeisha Chemical Co., Ltd.) Photopolymerizable component 22: 2-(o-phenylphenoxy)ethyl acrylate (HRD-01, Nisshoku Techno Fine Chemical Co., Ltd.) Photopolymerizable component 23: 2-hydroxy-3-phenoxypropyl acrylate (M600-A, Kyoeisha Chemical Co., Ltd.)
[0159]
[0160] <Photopolymerization Initiator> In Tables 1 to 3, compounds classified as photopolymerization initiators are specifically the following photopolymerization initiators 1 and 2.
[0161] Photopolymerization initiator 1: acylphosphine oxide compound (Omnirad TPO: "Omnirad TPO" manufactured by IGM Resins B.V.) Photopolymerization initiator 2: acylphosphine oxide compound (Omnirad 819: "Omnirad 819" manufactured by IGM Resins B.V.)
[0162] (Production Example 1: Production of UDA) 372 g (3.20 mol) of HEA, 0.71 g of DBTDL (0.1% by mass relative to the total mass of HEA and TMHDI), and 0.35 g of MEHQ (0.05% by mass relative to the total mass of HEA and TMHDI) were added to a 1-liter four-neck flask equipped with a thoroughly dried stirring blade and a thermometer, and the mixture was stirred until homogeneous. The mixture was then heated to 60°C. Subsequently, 337 g (1.60 mol) of TMHDI was added dropwise over 1 hour. Since the internal temperature rose due to the heat of reaction during the addition, the amount added was controlled to keep the temperature below 80°C. After the entire amount was added dropwise, the reaction temperature was maintained at 80°C and the reaction was carried out for 10 hours. The progress of the reaction was monitored by HPLC analysis to confirm the end point of the reaction. The product was discharged from the reactor to obtain 680 g of bifunctional urethane acrylate (UDA). The viscosity at 25°C was 7100 mPa·s.
[0163] (Production Example 2: Production of UDA2) 232 g (2.00 mol) of HEA, 0.48 g (0.1% by mass relative to the total mass of HEA and TMXDI), and 0.24 g (0.05% by mass relative to the total mass of HEA and TMXDI) of MEHQ were added to a 1-liter four-neck flask equipped with a thoroughly dried stirring blade and a thermometer. The mixture was stirred until homogeneous and then heated to 60°C. Subsequently, 244 g (1.00 mol) of TMXDI was added dropwise over 1 hour. Since the internal temperature rose due to the heat of reaction during the addition, the amount added was controlled to keep the temperature below 80°C. After the entire amount was added dropwise, the reaction temperature was maintained at 80°C and the reaction was carried out for 10 hours. The progress of the reaction was monitored by HPLC analysis to confirm the end point of the reaction. The product was discharged from the reactor to obtain 455 g of a bifunctional urethane acrylate (UDA2). The viscosity at 65°C was 2200 mPa·s.
[0164] The abbreviations for the compounds used in the examples of the present disclosure are as follows: HEA: hydroxyethyl acrylate DBTDL: dibutyltin dilaurate MEHQ: 4-methoxyphenol TMHDI: mixture of 2,2,4-trimethylhexamethylene diisocyanate and 2,4,4-trimethylhexamethylene diisocyanate TMXDI: 1,3-tetramethylxylylene diisocyanate
[0165] As shown in Tables 1 to 3, by using the photocurable compositions of each Example, it was possible to ensure high transparency while maintaining mechanical strength, compared to when the photocurable compositions of each Comparative Example were used.
[0166] Examples 1B to 25B, Comparative Examples 1B to 10B Preparation of Photocurable Compositions The components shown in Tables 4 to 7 were mixed to obtain photocurable compositions.
[0167] <Measurements and Evaluations> The photocurable compositions obtained were subjected to the following measurements and evaluations. The results are shown in Tables 4 to 7.
[0168]
[0169]
[0170]
[0171]
[0172] In Tables 4 to 7, the numbers in the "Composition" column for each Example and Comparative Example mean parts by mass, and blank spaces mean that the corresponding component is not contained. In Tables 4 to 7, the compounds classified as (meth)acrylic monomer (B) and (meth)acrylic monomer (C) are specifically as described above. In Tables 4 to 7, the compounds classified as photopolymerization initiators are specifically photopolymerization initiators 1 to 4 shown below.
[0173] Photopolymerization initiator 1: acylphosphine oxide compound (Omnirad TPO: "Omnirad TPO" manufactured by IGM Resins B.V.) Photopolymerization initiator 2: acylphosphine oxide compound (Omnirad 819: "Omnirad 819" manufactured by IGM Resins B.V.) Photopolymerization initiator 3: alkyl benzoyl formate compound (MBF, BASF) Photopolymerization initiator 4: alkyl benzoyl formate compound (EBF, Tokyo Chemical Industry Co., Ltd.)
[0174]
[0175] As shown in Tables 4 to 7, by using the photocurable compositions of each Example, it was possible to ensure high transparency while maintaining mechanical strength, compared to when the photocurable compositions of each Comparative Example were used.
[0176] The disclosures of Japanese Patent Application Nos. 2022-052226, filed on March 28, 2022, and 2022-052227, filed on March 28, 2022, are incorporated herein by reference in their entirety. All documents, patent applications, and technical standards described herein are incorporated herein by reference to the same extent as if each individual document, patent application, and technical standard was specifically and individually indicated to be incorporated by reference.
Claims
1. A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, The photocurable composition was irradiated with visible light having a wavelength of 405 nm at a dose of 11 mJ / cm 2 The cured layers A1 are laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm. The object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at a dose of 10 J / cm. 2 After irradiation, both sides of the 50 mm × 40 mm surface were polished to prepare a rectangular plate-shaped test piece A1 having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm. The ΔE * ab is 6.0 or less, The photocurable composition was irradiated with visible light having a wavelength of 405 nm at a dose of 11 mJ / cm 2 The cured layers A1 are laminated in the thickness direction to form a rectangular plate-shaped object A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm. The object A2 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J / cm. 2 When a rectangular plate-shaped test piece A2 having a length of 64 mm, a width of 10 mm, and a thickness of 3.3 mm is prepared by irradiating the photocurable composition, the test piece A2 has a bending strength of 50 MPa or more and a bending modulus of elasticity of 1,500 MPa or more.
2. The photopolymerizable component is one or more (meth)acrylic monomers (A) selected from the group consisting of a mono(meth)acrylic monomer (A-1) having one (meth)acryloyloxy group and no cyclic structure, and a di(meth)acrylic monomer (A-2) having two (meth)acryloyloxy groups, no cyclic structure, and in which the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is 25 Å or more; one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups; A (meth)acrylic monomer (C) having one (meth)acryloyloxy group and an aromatic structure; The photocurable composition of claim 1 comprising:
3. A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, The photopolymerizable component is one or more (meth)acrylic monomers (A) selected from the group consisting of a mono(meth)acrylic monomer (A-1) having one (meth)acryloyloxy group and no cyclic structure, and a di(meth)acrylic monomer (A-2) having two (meth)acryloyloxy groups, no cyclic structure, and in which the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is 25 Å or more; one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups; A (meth)acrylic monomer (C) having one (meth)acryloyloxy group and an aromatic structure; 1. A photocurable composition comprising:
4. The photocurable composition according to claim 2 or claim 3, which satisfies at least one of the following (1) or (2): (1) The (meth)acrylic monomer (A) contains the mono(meth)acrylic monomer (A-1), and the molecular weight of the mono(meth)acrylic monomer (A-1) is 100 to 500. (2) The photocurable composition according to claim 2, wherein, when the (meth)acrylic monomer (A) contains the di(meth)acrylic monomer (A-2), the molecular weight of the di(meth)acrylic monomer (A-2) is 400 to 1,000.
5. The photocurable composition according to claim 2 or 3, which satisfies at least one of the following (3) to (5): (3) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-1), and the molecular weight of the di(meth)acrylic monomer (B-1) is 200 to 800. (4) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), and the molecular weight of the di(meth)acrylic monomer (B-2) is 170 to 700. (5) The (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), and the molecular weight of the tri(meth)acrylic monomer (B-3) is 200 to 1,500.
6. The photocurable composition according to claim 2 or 3, wherein the (meth)acrylic monomer (C) has a molecular weight of 140 to 500.
7. 4. The photocurable composition according to claim 2, wherein the content of the (meth)acrylic monomer (A) is 1% by mass to 20% by mass based on the total amount of the (meth)acrylic monomer components.
8. The photocurable composition according to claim 2 or 3, wherein the content of the (meth)acrylic monomer (B) is 25% by mass to 90% by mass based on the total amount of the (meth)acrylic monomer components.
9. The photocurable composition according to claim 2 or 3, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 70% by mass based on the total amount of the (meth)acrylic monomer components.
10. The photocurable composition according to any one of claims 1 to 3, wherein the photopolymerization initiator comprises an acylphosphine oxide compound.
11. A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, The photocurable composition, wherein the photopolymerization initiator comprises an acylphosphine oxide compound and an alkyl benzoylformate compound.
12. The photopolymerizable component is one or more (meth)acrylic monomers (B) selected from the group consisting of a di(meth)acrylic monomer (B-1) having two (meth)acryloyloxy groups and having a cyclic structure, a di(meth)acrylic monomer (B-2) (excluding the di(meth)acrylic monomer (B-1)) having two (meth)acryloyloxy groups and in which the distance between an oxygen atom forming an oxy group in one (meth)acryloyloxy group and an oxygen atom forming an oxy group in the other (meth)acryloyloxy group is less than 25 Å, and a tri(meth)acrylic monomer (B-3) having three (meth)acryloyloxy groups; A (meth)acrylic monomer (C) having one (meth)acryloyloxy group and an aromatic structure; The photocurable composition of claim 11 comprising:
13. The photocurable composition according to claim 12, which satisfies at least one of the following (1) to (3): (1) the (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-1), and the molecular weight of the di(meth)acrylic monomer (B-1) is 200 to 800. (2) The (meth)acrylic monomer (B) contains the di(meth)acrylic monomer (B-2), and the molecular weight of the di(meth)acrylic monomer (B-2) is 170 to 700. (3) The (meth)acrylic monomer (B) contains the tri(meth)acrylic monomer (B-3), and the molecular weight of the tri(meth)acrylic monomer (B-3) is 200 to 1,500.
14. The photocurable composition according to claim 12 or 13, wherein the (meth)acrylic monomer (C) has a molecular weight of 140 to 500.
15. The photocurable composition according to claim 12 or 13, wherein the content of the (meth)acrylic monomer (B) is 25% by mass to 95% by mass based on the total amount of the (meth)acrylic monomer components.
16. The photocurable composition according to claim 12 or 13, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 75% by mass based on the total amount of the (meth)acrylic monomer components.
17. The photocurable composition according to any one of claims 1 to 3 and claim 11, having a viscosity of 5 mPa·s to 6000 mPa·s as measured with an E-type viscometer at 25°C and 50 rpm.
18. The photocurable composition according to any one of claims 1 to 3 and claim 11, which is a photocurable composition for stereolithography.
19. The photocurable composition according to any one of claims 1 to 3 and claim 11, which is used for producing a splint by stereolithography.
20. A three-dimensional object comprising a cured product of the photocurable composition according to any one of claims 1 to 3 and 11.
21. A dental product comprising the three-dimensional object according to claim 20.
22. A splint comprising the three-dimensional object according to claim 20.
